<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler</dc:title>
  <dc:creator>BENSCH, George</dc:creator>
  <dc:creator>LAPIDUS, Robert J</dc:creator>
  <dc:creator>LEVINE, Bernard E</dc:creator>
  <dc:creator>LUMRY, William</dc:creator>
  <dc:creator>YEGEN, Omit</dc:creator>
  <dc:creator>KISELEV, Pavel</dc:creator>
  <dc:creator>DELLA CIOPPA, Giovanni</dc:creator>
  <dc:contributor>American College of Allergy, Asthma &amp; Immunology (Funder/Sponsor)</dc:contributor>
  <dc:contributor>American College of Allergy, Asthma &amp; Immunology. Annual meeting (Seattle 2000-11-03)</dc:contributor>
  <dc:relation>Annals of allergy, asthma, &amp; immunology -- Ann. allergy asthma immunol, ISSN 1081-1206, Vol. 86 (1) , pp. 19-27</dc:relation>
  <dc:relation>American College of Allergy, Asthma &amp; Immunology. Annual meeting</dc:relation>
  <dc:date>2001</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Conference Paper</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>American College of Allergy, Asthma, &amp; Immunology</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>24 ref</dc:format>
  <dc:subject xml:lang="fr">Appareil respiratoire pathologie</dc:subject>
  <dc:subject xml:lang="fr">Bronchopneumopathie obstructive</dc:subject>
  <dc:subject xml:lang="fr">Immunopathologie</dc:subject>
  <dc:subject xml:lang="fr">Agoniste</dc:subject>
  <dc:subject xml:lang="fr">Allergie</dc:subject>
  <dc:subject xml:lang="fr">Antiasthmatique</dc:subject>
  <dc:subject xml:lang="fr">Asthme</dc:subject>
  <dc:subject xml:lang="fr">Aérosol</dc:subject>
  <dc:subject xml:lang="fr">Bronchodilatateur</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Efficacité traitement</dc:subject>
  <dc:subject xml:lang="fr">Etude comparative</dc:subject>
  <dc:subject xml:lang="fr">Etude double insu</dc:subject>
  <dc:subject xml:lang="fr">Formotérol</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Inhalation</dc:subject>
  <dc:subject xml:lang="fr">Randomisation</dc:subject>
  <dc:subject xml:lang="fr">Récepteur β2-adrénergique</dc:subject>
  <dc:subject xml:lang="fr">Stimulant β-adrénergique</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Respiratory disease</dc:subject>
  <dc:subject xml:lang="en">Obstructive pulmonary disease</dc:subject>
  <dc:subject xml:lang="en">Immunopathology</dc:subject>
  <dc:subject xml:lang="en">Agonist</dc:subject>
  <dc:subject xml:lang="en">Allergy</dc:subject>
  <dc:subject xml:lang="en">Antiasthma agent</dc:subject>
  <dc:subject xml:lang="en">Asthma</dc:subject>
  <dc:subject xml:lang="en">Aerosols</dc:subject>
  <dc:subject xml:lang="en">Bronchodilator</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Treatment efficiency</dc:subject>
  <dc:subject xml:lang="en">Comparative study</dc:subject>
  <dc:subject xml:lang="en">Double blind study</dc:subject>
  <dc:subject xml:lang="en">Formoterol</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Inhalation</dc:subject>
  <dc:subject xml:lang="en">Randomization</dc:subject>
  <dc:subject xml:lang="en">β2-Adrenergic receptor</dc:subject>
  <dc:subject xml:lang="en">β-Adrenergic receptor agonist</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Aparato respiratorio patología</dc:subject>
  <dc:subject xml:lang="es">Broncopneumopatía obstructiva</dc:subject>
  <dc:subject xml:lang="es">Inmunopatología</dc:subject>
  <dc:subject xml:lang="es">Agonista</dc:subject>
  <dc:subject xml:lang="es">Alergia</dc:subject>
  <dc:subject xml:lang="es">Agente antiasma</dc:subject>
  <dc:subject xml:lang="es">Asma</dc:subject>
  <dc:subject xml:lang="es">Aerosol</dc:subject>
  <dc:subject xml:lang="es">Broncodilatador</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Eficacia tratamiento</dc:subject>
  <dc:subject xml:lang="es">Estudio comparativo</dc:subject>
  <dc:subject xml:lang="es">Estudio doble ciego</dc:subject>
  <dc:subject xml:lang="es">Formoterol</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Inhalación</dc:subject>
  <dc:subject xml:lang="es">Aleatorización</dc:subject>
  <dc:subject xml:lang="es">Receptor β2-adrenérgico</dc:subject>
  <dc:subject xml:lang="es">Estimulante β-adrenérgico</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02J: Histamine et antagonistes. Allergie / Histamine and antagonists. Allergy</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 877853</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>